Company Overview
C4 THERAPEUTICS, INC.
CCCCRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
36M
2025 FY
Net Income
-105M
2025 FY
Shares Outstanding
83M
2025 FY
EPS
-1.27USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1662579
Exchange
Nasdaq
Location
US